HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"count": 1608389,
"next": "https://info.mzalendo.com/api/v0.1/hansard/entries/?format=api&page=150945",
"previous": "https://info.mzalendo.com/api/v0.1/hansard/entries/?format=api&page=150943",
"results": [
{
"id": 1527632,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1527632/?format=api",
"text_counter": 36,
"type": "heading",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "PREVALENCE AND MANAGEMENT OF HEPATITIS B IN KENYA"
},
{
"id": 1527633,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1527633/?format=api",
"text_counter": 37,
"type": "speech",
"speaker_name": "Sen. Wakili Sigei",
"speaker_title": "",
"speaker": null,
"content": "Mr. Speaker, Sir, I rise pursuant to Standing Order No.53 (1), to seek a Statement from the Standing Committee on Health regarding the prevalence and management of Hepatitis B in Kenya, particularly in the counties of Baringo, Migori and Turkana, which continue to report disproportionately high prevalence rates. In the Statement, the Committee should– (1) Report on the Hepatitis B crisis in Kenya, including the latest statistics on national prevalence, while highlighting the most impacted counties, particularly Baringo, Migori and Turkana counties. The electronic version of the Senate Hansard Report is for information purposesonly. A certified version of this Report can be obtained from the Director, Hansard and AudioServices, Senate."
},
{
"id": 1527634,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1527634/?format=api",
"text_counter": 38,
"type": "speech",
"speaker_name": "Sen. Wakili Sigei",
"speaker_title": "",
"speaker": null,
"content": "(2) Apprise the Senate on the measures currently being taken by the Cabinet Secretary for Health and the Kenya Medical Supplies Authority (KEMSA), to ensure the consistent availability and supply of Hepatitis B vaccines, especially in high prevalence regions, given the persisting vaccine shortages. (3) Inform the Senate of the accessibility rates by percentage per county of Hepatitis B vaccination in Kenya, specifically outlining any ongoing efforts to subsidise costs or provide vaccines free of charge to vulnerable populations. (4) Investigate the effectiveness of current screening programmes for Hepatitis B, particularly in remote and highly affected areas and highlight any recent or planned initiatives aimed at expanding screening and early detection efforts. (5) Report on the reach and impact of public awareness campaigns regarding Hepatitis B, detailing any ongoing or new strategies to enhance public education on prevention, transmission and treatment, particularly in counties with high prevalence. Mr. Speaker, Sir, I will proceed to read the second Statement, which was also approved pursuant to the earlier letter, in compliance with your ruling."
},
{
"id": 1527635,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1527635/?format=api",
"text_counter": 39,
"type": "heading",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "EASY ACCESSIBILITY AND ILLEGAL SALE OF OZEMPIC"
},
{
"id": 1527636,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1527636/?format=api",
"text_counter": 40,
"type": "speech",
"speaker_name": "Sen. Wakili Sigei",
"speaker_title": "",
"speaker": null,
"content": "Mr Speaker, Sir, I rise pursuant to Standing Order No.53 (1), to seek a Statement from the Standing Committee on Health regarding the easy accessibility and illegal sale of the diabetes prescription injectable drug, namely Ozempic, which is sold over the counter in the Kenyan market as semaglutide to be used for quick weight loss. Diabetes is a growing public health concern in Kenya, with patients relying on prescribed medications to manage the condition effectively. However, there is concern on the widespread over-the-counter sales of Ozempic injectable for use as a weight loss agent, with total disregard to the severe side effects, drug interactions and long-term complications, including the hypoglycemia and organ damage that may occur. In the Statement, the Committee should- (1) Highlight the regulatory measures in place that are intended to ensure that the sale of all prescription drugs, including Ozempic, are only dispensed at registered chemists and pharmacies, upon the production of a valid prescription following a medical consultation. (2) State the steps being taken by the Pharmacy and Poisons Board to ensure that the regulations on the sale and distribution of medicine, specifically prescription drugs such as Ozempic, are strictly adhered to. (3) State any interventions in place to – (a) Monitor, track and curb the illegal over-the-counter sale and distribution of"
},
{
"id": 1527637,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1527637/?format=api",
"text_counter": 41,
"type": "scene",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "Ozempic"
},
{
"id": 1527638,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1527638/?format=api",
"text_counter": 42,
"type": "speech",
"speaker_name": "Sen. Wakili Sigei",
"speaker_title": "",
"speaker": null,
"content": "and any other prescription drugs; and, (b) Seal any loopholes as set out in the Pharmacy and Poisons Board guidelines and to apprehend the rogue chemist/pharmacist. (4) State how the Pharmacy and Poisons Board has realigned its policies and operational guidelines to the devolved system of governance, to ensure that pharmaceutical oversight is strictly carried out and arrests and interdictions of the non- The electronic version of the Senate Hansard Report is for information purposesonly. A certified version of this Report can be obtained from the Director, Hansard and AudioServices, Senate."
},
{
"id": 1527639,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1527639/?format=api",
"text_counter": 43,
"type": "speech",
"speaker_name": "Sen. Wakili Sigei",
"speaker_title": "",
"speaker": null,
"content": "compliant vendors is implemented to read the practise of unscrupulous vendors, while educating the general public on the harms likely to be caused by the casual use of prescription drugs to achieve certain effects on human bodies. I thank you."
},
{
"id": 1527640,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1527640/?format=api",
"text_counter": 44,
"type": "speech",
"speaker_name": "Hon. Kingi",
"speaker_title": "The Speaker",
"speaker": null,
"content": " Proceed, Sen. Mundigi."
},
{
"id": 1527641,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1527641/?format=api",
"text_counter": 45,
"type": "heading",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "ENROLMENT PROCESS FOR SENIOR CITIZENS AND PWDS INTO SHA"
}
]
}